Vidailhet M, Mallet E, Bocquet A, Bresson J-L, Briend A, Chouraqui J-P, Darmaun D, Dupont C, Frelut M-L, Ghisolfi J, Girardet J-P, Goulet O, Hankard R, Rieu D, Simeoni U, Turck D
Service de pédiatrie et génétique clinique, hôpital d'enfants, université Henri-Poincaré, allée du Morvan, 54511 Vandœuvre-les-Nancy, France.
Arch Pediatr. 2012 Mar;19(3):316-28. doi: 10.1016/j.arcped.2011.12.015. Epub 2012 Jan 27.
The aims of the present position paper by the Committee on Nutrition of the French Society of Paediatrics were to summarize the recently published data on vitamin D in infants, children and adolescents, i.e., on metabolism, physiological effects, and requirements and to make recommendations on supplementation after careful review of the evidence. Scientific evidence indicates that calcium and vitamin D play key roles in bone health. The current evidence, limited to observational studies, however, does not support other benefits for vitamin D. More targeted research should continue, especially interventional studies. In the absence of any underlying risk of vitamin D deficiency, the recommendations are as follows: pregnant women: a single dose of 80,000 to 100,000 IU at the beginning of the 7th month of pregnancy; breastfed infants: 1000 to 1200 IU/day; children less than 18 months of age, receiving milk supplemented with vitamin D: an additional daily dose of 600 to 800 IU; children less than 18 months of age receiving milk not supplemented with vitamin D: daily dose of 1000 to 1200 IU; children from 18 months to 5 years of age: 2 doses of 80,000 to 100,000 IU every winter (November and February). In the presence of an underlying risk of vitamin D deficiency (dark skin; lack of exposure of the skin to ultraviolet B [UVB] radiation from sunshine in summer; skin disease responsible for decreased exposure of the skin to UVB radiation from sunshine in summer; wearing skin-covering clothes in summer; intestinal malabsorption or maldigestion; cholestasis; renal insufficiency; nephrotic syndrome; drugs [rifampicin; antiepileptic treatment: phenobarbital, phenytoin]; obesity; vegan diet), it may be justified to start vitamin D supplementation in winter in children 5 to 10 years of age as well as to maintain supplementation of vitamin D every 3 months all year long in children 1 to 10 years of age and in adolescents. In some pathological conditions, doses of vitamin D can be increased. If necessary, the determination of 25(OH) vitamin D serum concentration will help determine the level of vitamin D supplementation.
法国儿科学会营养委员会撰写本立场文件的目的是总结近期发表的关于婴儿、儿童和青少年维生素D的相关数据,即维生素D的代谢、生理作用、需求量,并在仔细审查证据后就维生素D补充剂给出建议。科学证据表明,钙和维生素D对骨骼健康起着关键作用。然而,目前仅限于观察性研究的证据并不支持维生素D的其他益处。应继续开展更具针对性的研究,尤其是干预性研究。在不存在维生素D缺乏潜在风险的情况下,建议如下:孕妇:在妊娠第7个月开始时单次服用80,000至100,000国际单位;母乳喂养的婴儿:每日1000至1200国际单位;18个月以下且饮用添加了维生素D的牛奶的儿童:每日额外补充600至800国际单位;18个月以下且饮用未添加维生素D的牛奶的儿童:每日剂量为1000至1200国际单位;18个月至5岁的儿童:每年冬季(11月和2月)服用2剂80,000至100,000国际单位。在存在维生素D缺乏潜在风险的情况下(肤色较深;夏季皮肤未暴露于阳光中的紫外线B [UVB] 辐射;导致夏季皮肤暴露于阳光中紫外线B辐射减少的皮肤病;夏季穿着覆盖皮肤的衣物;肠道吸收不良或消化功能不良;胆汁淤积;肾功能不全;肾病综合征;药物 [利福平;抗癫痫治疗:苯巴比妥、苯妥英];肥胖;纯素饮食),5至10岁儿童在冬季开始补充维生素D以及1至10岁儿童和青少年全年每3个月维持补充维生素D可能是合理的。在某些病理情况下,可增加维生素D的剂量。如有必要,检测血清25(OH)维生素D浓度将有助于确定维生素D补充水平。